Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report) shares crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 6.85 ($0.09) and traded as low as GBX 6.70 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares trading hands.
Venn Life Sciences Trading Up 7.0 %
The company has a quick ratio of 1.48, a current ratio of 2.30 and a debt-to-equity ratio of 35.83. The stock has a market capitalization of £4.89 million and a PE ratio of -2.14. The business’s fifty day moving average is GBX 6.85 and its 200-day moving average is GBX 6.85.
About Venn Life Sciences
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Featured Articles
- Five stocks we like better than Venn Life Sciences
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- The Average 401k Balance by Age Explained
- How to Calculate Return on Investment (ROI)
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What Are Dividend Challengers?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.